Leveraging Omics Approaches to Identify and Select Highly Potent NK Cell Products
Time: 3:30 pm
day: Day One
Details:
- Uncovering the source of heterogeneity in NK cells using transcriptomics and proteomics approaches
- Identifying the biological differences of superior effectors, to produce more effective therapies
- Applying signatures of superior donors to product development, with the future goal of identifying them as early as the stem cell stage
